KamińskaK,GołembiowskaK,RogóżZ.Effectofrisperidoneonthefluoxetine-inducedchangesinextracellulardopamine,SEROtoninandnoradrenalineintheratfrontalcortex.PharmacolRep.2013;65(5):1144-51.PMID:24399710.
MacDowellKS,García-BuenoB,MadrigalJL,etal.Risperidonenormalizesincreasedinflammatoryparametersandrestoresanti-inflammatorypathwaysinamodelofneuroinflammation.IntJNeuropsychopharmacol.2013Feb;16(1):121-35.PMID:22176740.
KozielskaM,JohnsonM,PillaReddyV,etal.Pharmacokinetic-pharmacodynamicmodelingoftheD2and5-HT(2A)receptoroccupancyofrisperidoneandpaliperidoneinrats.PharmRes.2012Jul;29(7):1932-48.PMID:22437487.
AbouEl-MagdRM,ParkHK,KawazoeT,etal.TheeffectofrisperidoneonD-aminoacidoxidaseactivityasahypothesisforanovelmechanismofactioninthetreatmentofschizophrenia.JPsychopharmacol.2010Jul;24(7):1055-67.PMID:19329549.
TooheyN,KleinMT,KnightJ,etal.Human5-HT7receptor-inducedinactivationofforskolin-stimulatedadenylatecyclasebyrisperidone,9-OH-risperidoneandother"inactivatingantagonists".MolPharmacol.2009Sep;76(3):552-9.PMID:19509219.
PotkinSG,SahaAR,KujawaMJ,etal.Aripiprazole,anantipsychoticwithanovelmechanismofaction,andrisperidonevsplaceboinpatientswithschizophreniaandschizoaffectivedisorder.ArchGenPsychiatry.2003Jul;60(7):681-90.PMID:12860772.
FardeL,NybergS,OxenstiernaG,etal.PositronemissiontomographystudiesonD2and5-HT2receptorbindinginrisperidone-treatedschizophrenicpatients.JClinPsychopharmacol.1995Feb;15(1Suppl1):19S-23S.PMID:7537284.